Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus StatementThein, Anna-Sophie ; Hedengran, Anne ; Azuara-Blanco, Augusto ; Arita, Reiko ; Cvenkel, Barbara ; Gazzard, Gus ; Heegaard, Steffen ; de Paiva, Cintia S. ; Petrovski, Goran ; Prokosch-Willing, Verena ; Utheim, Tor P. ; Virgili, Gianni ; Kolko, MiriamAmerican journal of ophthalmology, 2022-09, Vol.241, p.190-197 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentageFernández de Larrea, Carlos ; Kyle, Robert ; Rosiñol, Laura ; Paiva, Bruno ; Engelhardt, Monika ; Usmani, Saad ; Caers, Jo ; Gonsalves, Wilson ; Schjesvold, Fredrik ; Merlini, Giampaolo ; Lentzch, Suzanne ; Ocio, Enrique ; Garderet, Laurent ; Moreau, Philippe ; Sonneveld, Pieter ; Badros, Ashraf ; Gahrton, Gösta ; Goldschmidt, Hartmut ; Tuchman, Sascha ; Einsele, Hermann ; Durie, Brian ; Wirk, Baldeep ; Musto, Pellegrino ; Hayden, Patrick ; Kaiser, Martin ; Miguel, Jesús San ; Bladé, Joan ; Rajkumar, S Vincent ; Mateos, Maria VictoriaBlood cancer journal (New York), 2021-12, Vol.11 (12), p.192-192, Article 192 [Periódico revisado por pares]United States: Springer Nature B.VTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Cobimetinib alone and plus venetoclax with/without atezolizumab in patients with relapsed/refractory multiple myelomaSchjesvold, Fredrik Hellem ; Paiva, Bruno ; Ribrag, Vincent ; Rodriguez-Otero, Paula ; San-Miguel, Jesus F ; Robak, Pawel ; Hansson, Markus ; Onishi, Maika ; Hamidi, Habib ; Malhi, Vikram ; Dail, Monique ; Javery, Apurva ; Ku, Grace ; Raab, Marc SClinical lymphoma, myeloma and leukemia, 2022 [Periódico revisado por pares]CIG Media Group, LPTexto completo disponível |